Scott T. Rottinghaus - Net Worth and Insider Trading
Scott T. Rottinghaus Net Worth
The estimated net worth of Scott T. Rottinghaus is at least $371,583 dollars as of 2024-05-01. Scott T. Rottinghaus is the Sr. VP & CMO of Enanta Pharmaceuticals Inc and owns about 26,466 shares of Enanta Pharmaceuticals Inc (ENTA) stock worth over $371,583. Details can be seen in Scott T. Rottinghaus's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Scott T. Rottinghaus has not made any transactions after 2023-12-05 and currently still holds the listed stock(s).
Transaction Summary of Scott T. Rottinghaus
Scott T. Rottinghaus Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Scott T. Rottinghaus owns 1 companies in total, including Enanta Pharmaceuticals Inc (ENTA) .
Click here to see the complete history of Scott T. Rottinghaus’s form 4 insider trades.
Insider Ownership Summary of Scott T. Rottinghaus
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | Chief Medical Officer |
Scott T. Rottinghaus Latest Holdings Summary
Scott T. Rottinghaus currently owns a total of 1 stock. Scott T. Rottinghaus owns 26,466 shares of Enanta Pharmaceuticals Inc (ENTA) as of December 5, 2023, with a value of $371,583.
Latest Holdings of Scott T. Rottinghaus
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc | 2023-12-05 | 26,466 | 14.04 | 371,583 |
Holding Weightings of Scott T. Rottinghaus
Scott T. Rottinghaus Form 4 Trading Tracker
According to the SEC Form 4 filings, Scott T. Rottinghaus has made a total of 1 transactions in Enanta Pharmaceuticals Inc (ENTA) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Enanta Pharmaceuticals Inc is the sale of 534 shares on December 5, 2023, which brought Scott T. Rottinghaus around $5,142.
Insider Trading History of Scott T. Rottinghaus
- 1
Scott T. Rottinghaus Trading Performance
Scott T. Rottinghaus Ownership Network
Ownership Network List of Scott T. Rottinghaus
Ownership Network Relation of Scott T. Rottinghaus
Scott T. Rottinghaus Owned Company Details
What does Enanta Pharmaceuticals Inc do?
Who are the key executives at Enanta Pharmaceuticals Inc?
Scott T. Rottinghaus is the Chief Medical Officer of Enanta Pharmaceuticals Inc. Other key executives at Enanta Pharmaceuticals Inc include Sr. VP & Business Dev. Brendan Luu , Sr. VP & New Product Dev. Tara Lynn Kieffer , and Chief Scientific Officer Yat Sun Or .
Enanta Pharmaceuticals Inc (ENTA) Insider Trades Summary
Over the past 18 months, Scott T. Rottinghaus made 1 insider transaction in Enanta Pharmaceuticals Inc (ENTA) with a net sale of 534. Other recent insider transactions involving Enanta Pharmaceuticals Inc (ENTA) include a net sale of 65,142 shares made by Jay R. Luly , a net sale of 16,337 shares made by Yat Sun Or , and a net sale of 12,852 shares made by Paul J Mellett .
In summary, during the past 3 months, insiders sold 0 shares of Enanta Pharmaceuticals Inc (ENTA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 116,822 shares of Enanta Pharmaceuticals Inc (ENTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 116,822 shares.
Enanta Pharmaceuticals Inc (ENTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Enanta Pharmaceuticals Inc Insider Transactions
Scott T. Rottinghaus Mailing Address
Above is the net worth, insider trading, and ownership report for Scott T. Rottinghaus. You might contact Scott T. Rottinghaus via mailing address: C/o Enanta Pharmaceuticals, Inc., 500 Arsenal Street, Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
